- Abstract Number: 1799
Validating the Gouty Arthritis Alleviating Effects of Cerevisterol through Integrated In Silico, In Vitro, and In Vivo Studies
- Abstract Number: 1217
Validation and clincial use of anti-MDA5 test – LIA versus ELISA
- Abstract Number: 2503
Validation of a Composite Biomarker Score To Predict Modified Rodnan Skin Score: Insight From Autologous Stem Cell Transplantation International Scleroderma trial
- Abstract Number: 1564
Validation of a Composite Endpoint for Systemic Sclerosis-Associated Interstitial Lung Disease
- Abstract Number: 2333
Validation of a Corrected Axial Spondyoarthritis Metrology Index in 9 Randomized Clinical Trials
- Abstract Number: 1125
Validation of an Allopurinol Dose Prediction Tool to Achieve Goal Serum Urate Among Patients with Gout
- Abstract Number: 0186
Validation of Asynchronous Telehealth Visit for Adults and Children with Inflammatory Arthritis and Feasibility of Applying Thermal Imaging during Visits
- Abstract Number: 1479
Validation of Attention, Memory, and Frontal-Executive Abilities Screening Test (AMFAST) in Systemic Lupus Erythematosus (SLE), a prospective single-center study in The Bronx
- Abstract Number: 2032
Validation of systemic Juvenile Arthritis Disease Activity Score 10 (sJADAS 10) in adult patients with Still’s Disease
- Abstract Number: 1630
Validation of the classification algorithm using the modified 2022 ACR/EULAR giant cell arteritis classification criteria and Japanese Takayasu arteritis diagnostic criteria
- Abstract Number: 1103
Validation of the Health Assessment Questionnaire Disability Index in Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
- Abstract Number: 1204
Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis.
- Abstract Number: 2009
Value of New PREVENT Calculator in Detecting Cardiovascular Disease in Patients with Gout
- Abstract Number: 2504
Variables Associated with In-Hospital Mortality in Adult Eosinophilic Granulomatosis with Polyangiitis from the National Inpatient Sample Database 2017-2021
- Abstract Number: 1131
Variant Drives Tophus Formation through Dual Mechanisms: Extracellular Aggregation andvImpaired Macrophage Phagocytic Clearance
- Abstract Number: 0198
Variation in RA disease activity measure assessment and treatment change documentation in virtual vs in-office rheumatology visits
- Abstract Number: 2537
Variation in Treatment Approaches in IgA-Vasculitis Among Pediatricians and Pediatric rheumatologists: A Cross-Sectional International Survey
- Abstract Number: 0710
Vascular Events in Systemic Sclerosis Patients with Anti-Phospholipid Antibodies
- Abstract Number: 1562
Vasodilation with Prostanoids Influences Progression of Systemic Sclerosis-Associated Interstitial Lung Disease: a EUSTAR Cohort Study
- Abstract Number: 0611
Venous Thromboembolism in Patients with Lupus Nephritis: Frequency and Risk Factors – A Cohort Study
- Abstract Number: 1882
Vessels Under Fire: National Mortality Trends in Systemic Vasculitides in the United States, 1999–2020
- Abstract Number: 1236
Vestibulocortical Stimulation via Caloric Irrigation in Nociplastic Disease: Therapeutic Effects on Pain, Autonomic Functioning & Quality of Life Measures
- Abstract Number: 0768
Veteran Rehabilitation, Physical Therapy Care Delivery, and Outcomes after Total Knee Arthroplasty
- Abstract Number: 1171
VEXAS Syndrome Under the Lens: A prospective analysis of temporal disease patterns, biomarker Dynamics, and therapeutic efficacy
- Abstract Number: 1918
Vigorous Physical Activity in Patients with SLE Was Not Associated with Disease Activity or Socioeconomic and Social Factors
- Abstract Number: 1176
VISIBLE Post-Inflammatory Pigmentation Journeys: Exploring the Impact of Pigmentation
- Abstract Number: 1490
Vitamin D Deficiency and Its Relationship with Inflammatory Biomarkers in SLE: A Focus on Neutrophil-to-Lymphocyte Ratio
- Abstract Number: 1544
Voclosporin in Lupus Nephritis: Meta-Analysis of 6-Month and 1-Year Efficacy with 1-Year Safety Outcomes
ACR Convergence 2025
October 24-29, 2025. Chicago, Illinois.